Glomerular Filtration rate and its determinants.pptx
Mucopolysaccharidoses
1. Mucopolysaccharidoses
Prof. Dr. Saad S Al Ani
Senior Pediatric Consultant
Head of Pediatric Department
Khorfakkan Hospital
Sharjah ,UAE
saadsalani@aol.com
2. Mucopolysaccharidoses
Hereditary, progressive diseases caused by
mutations of genes coding for lysosomal
enzymes needed to degrade glycosaminoglycans
(GAGs) (acid mucopolysaccharides).
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
2
8. Proteoglycans degradation disturbance
(cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital8
printablecolouringpages.co.uk
Distended
lysosomes
cell
function
Characteristic pattern of clinical, radiologic, and
biochemical abnormalities
Specific diseases can be recognized that evolve from the
intracellular accumulation of different degradation products
9. Rule of fingers
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
9
Heparan sulfate
(impaired degradation)
Mental
deficiency
Dermatan sulfate,
Chondroitin
sulfates,
Keratan sulfate
(impaired degradation)
Mesenchymal
abnormalities
11. Mucopolysaccharidoses (cont.)
Overall frequency is between
3.5/100,000 and 4.5/100,000
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
11
teamsanfilippo.org
http://dxline.info/
Diseases /hurler-
syndrome
flipper.diff.org
The most common subtype is
Sanfilippo disease (MPS-III)
followed by Hurler disease
( MPS-I )
And Hunter disease (MPS II
12. Sanfilippo Syndrome(MPSIII)
A deficiency in one of the enzymes required to
break down glycosaminoglycan heparan sulfate
(found on the cell surface glycoproteins and
also in extra-cellular matrix)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
12
http://www.primehealthchannel.com/sanfilippo-syndrome
A rare form of lysosomal storage disease
Inherited in an autosomal recessive pattern
www.primehealthchannel.com
13. Sanfilippo Syndrome (cont.)
• The incidence vary geographically, One per:
- 50000 people in the Netherlands
- 66000 people in Australia
- 280000 cases in Northern Ireland
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
13
http://www.primehealthchannel.com/sanfilippo-syndrome
www.internationalstudentinsurance.com
www.gapyear.com
www.carhirecomparison.ie
14. Sanfilippo Syndrome (cont.)
Deficiency in one of the four enzymes:
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
14
1. Heparan N- sulfatase (type A)
16. Sanfilippo Syndrome (cont.)
3. Acetyl -Co Alpha- glucosaminide
acetyltransferase (type C)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
16
17. Sanfilippo Syndrome (cont.)
4.N- acetylglucosamine 6-sulfatase (type D)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
17
18. Sanfilippo Syndrome (cont.)
Patients are characterized by slowly progressive,
severe CNS involvement with mild somatic
disease
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
18
Onset of clinical features usually occurs between
2 and 6 yr in a child who previously appeared
normal.
19. Sanfilippo Syndrome (cont.)
Presenting features include:
– Delayed development
– Hyperactivity with aggressive behavior
– Coarse hair
– Hirsutism
– Sleep disorders
– Mild hepatosplenomegaly
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
19
articleactive.com
20. Sanfilippo Syndrome (cont.)
Severe neurologic deterioration occurs in most
patients by 6-10 yr of age, accompanied by rapid
deterioration of social and adaptive skills
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
20
ellendelbloggolo.blogspot.com
21. Sanfilippo Syndrome (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
21
ellendelbloggolo.blogspot.com
Severe behavior problems such as:
- Sleep disturbance
- Uncontrolled hyperactivity
- Temper tantrums
- Destructive behavior
- Physical aggression
are common
22. Sanfilippo Syndrome (cont.)
Delays in diagnosis of MPS III are common
due to :
- Mild physical features
- Hyperactivity
- Slowly progressive neurologic disease
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
22
rareshare.org
23. MPS 1
MPS I is caused by mutations of the IUA
gene on chromosome 4p16.3 encoding α-L-
iduronidase
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
23
www.patienthelp.org
24. MPS1 (cont.)
Deficiency of α-L- iduronidase results in a
broad clinical spectrum, from severe Hurler
disease to mild Scheie diseases
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
24
www.patienthelp.org
25. Hurler Disease (MPS I)
This is a severe form of MPS I ,and it is
progressive disorder with multiple organ and
tissue involvement that results in premature
death, usually by 10 yr of age
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
25
www.eyecalcs.com
26. Hurler Disease (cont.)
An infant with Hurler syndrome appears
normal at birth, but inguinal hernias are often
present
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
26
www.eyecalcs.com
28. Hurler Disease (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
28
www.eyecalcs.com
Cardiac involvement include:
• Valvular heart disease:
Mitral and Aortic valves incompetence
• Coronary artery narrowing
Obstructive airway disease, notably during
sleep, may necessitate tracheotomy.
29. Hurler Disease (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
29
www.eyecalcs.com
Most children with Hurler syndrome acquire
social but only limited language skills
because of :
• Developmental delay
• Combined conductive and neurosensory
hearing loss
• An enlarged tongue
30. Hurler Disease (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
30
www.eyecalcs.com
Headache and sleep disturbance due to:
Progressive ventricular enlargement with
increased intracranial pressure caused by
communicating hydrocephalus
33. Hurler Disease (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
33
www.eyecalcs.com
Radio-graphs show a
characteristic skeletal
dysplasia known as
dysostosis multiplex
The earliest radiographic
signs are thick ribs and
ovoid vertebral bodies
http://www.keywordpicture.com/keyword/arthrogryposis%20multiplex
http://www.maroteaux-lamy.com/Turkish/HCP/Bones.aspx
34. Hurler Disease (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
34
www.eyecalcs.com
With progression of the disease macrocephaly
develops, with:
• Thickened calvarium
• Premature closure of lambdoid and
sagittal sutures
• Shallow orbits
36. Hurler Disease (cont.) Diagnosis
Usually made between 6 and 24 mo of age
with evidence of:
– Hepatosplenomegaly
– Coarse facial features
– Corneal clouding
– Large tongue
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
36
www.eyecalcs.com
nlm.nih.gov
37. Hurler Disease (cont.) Diagnosis
-Prominent forehead
– Joint stiffness
– Short stature
– Skeletal dysplasia
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
37
www.eyecalcs.com
http://www.scripps.org/articles/99-frontal-bossing
http://www.nemours.org/service/medical/skeletal-dysplasia
http://doctorsgates.blogspot.ae
http://emedicine.medscape.com/article/951148-overview
39. Hunter disease (MPS II)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
39
Is an X-linked disorder caused by the
deficiency of iduronate-2-sulfatase (IDS)
flipper.diff.org
40. Hunter disease (MPS II) (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
40
flipper.diff.org
The gene encoding IDS is mapped to Xq28.
Point mutations of the IDS gene have been
detected in about 80% of patients with MPS II
Hunter disease manifests almost exclusively in
males. it has been observed in a few females
42. Hunter disease (MPS II) (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
42
flipper.diff.org
Patients with severe MPS II have features
similar to those of Hurler disease except for:
• Lack of corneal clouding
• Slower progression of:
Somatic and Central nervous system
(CNS) deterioration
43. Hunter disease (MPS II) (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
43
flipper.diff.org
Clinical manifestations:
• Coarse facial features
• Short stature
• Dysostosis multiplex
• Joint stiffness
• Mental retardation manifest between
2 and 4 yr of age.
44. Hunter disease (MPS II) (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
44
flipper.diff.org
The following may present
• Grouped skin papules
• Extensive Mongolian spots
• Chronic diarrhea
• Communicating hydrocephalus and
spastic paraplegia
45. Hunter disease (MPS II) (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
45
Patients with the mild form have:
• Prolonged life span
• Minimal CNS involvement
• Slow progression of somatic deterioration
with preservation of intelligence in adult
life
flipper.diff.org
46. Hunter disease (MPS II) (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
46
In severely affected patients:
• Extensive, slowly progressive neurologic
involvement
• Death, which usually occurs between 10
and 15 yr of age.
flipper.diff.org
47. Hunter disease (MPS II) (cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
47
In both the mild and severe forms:
• Airway involvement
• Valvular cardiac disease
• Hearing impairment
• Carpal tunnel syndrome
• Joint stiffness
Are common and can result in significant
loss of function
flipper.diff.org
48. Diagnosis of MPS
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
48
Any individual who is suspected of an MPS
disorder based on:
• Clinical features
• Radiographic results
• Urinary GAG screening tests
Should have a definitive diagnosis established
by enzyme assay
49. Differential diagnosis
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
49
1.Mucolipidoses
2.Oligosaccharidoses
In these conditions, the urinary excretion of
GAGs is not elevated
3. Neurodegenerative and dwarfing conditions
Mucopolysaccharidoses can be differentiate from
them by the present of:
• Hurler- like facial features
• Joint contractures
• Dysostosis multiplex
• Elevated urinary GAG excretion
50. Treatment of MPS
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
50
• Hematopoietic stem cell transplantation
results in significant clinical improvement of
somatic disease in MPS I, II, and VI
• Enzyme replacement using recombinant
enzymes is approved for patients with MPS I,
MPS II, and MPS VI.
51. Hematopoietic stem cell transplantation
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
51
Clinical effects include :
• Increased life expectancy
• Resolution or improvement of growth
failure
• Upper airway obstruction
• Hepatosplenomegaly
• Joint stiffness
• Facial appearance
52. Hematopoietic stem cell transplantation
(Cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
52
• Pebbly skin changes
• Obstructive sleep apnea
• Heart disease
• Communicating hydrocephalus
• Hearing loss
53. Hematopoietic stem cell transplantation
(Cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
53
Enzyme activity in serum and urinary GAG
excretion is normalized
Transplantation prevents neurocognitive
degeneration
54. Hematopoietic stem cell transplantation (Cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
54
Transplantation does not correct :
• Existent cerebral damage
• Skeletal and ocular anomalies
57. Enzyme replacement (Cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
57
-The enzymes do not:
• Cross the blood-brain barrier
• Prevent deterioration of neurocognitive
involvement.
-This therapy is the domain for patients with
mild central nervous involvement
58. Prevention
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
58
• Primary prevention
Through genetic counseling
• Tertiary prevention
To avoid or treat complications remains the
mainstay of supportive pediatric care
59. Prevention (Cont.)
3/1/2015
Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital
59
Multidisciplinary attention to:
• Respiratory and cardiovascular complications
• Hearing loss
• Carpal tunnel syndrome
• Spinal cord compression
• Hydrocephalus, and other problems
Can greatly improve the quality of life for
patients and their families